Pain affects more than 30% of adults around the world, and yet the only current options to deal with it either can harm your liver or be highly addictive. This is why it’s big news that local company South Rampart Pharma just finished Phase 1 trials on a pain killer that has shown neither of these issues. The company’s co-founder and John Ochsner Endowed Professor of Surgery in Innovation, Dr. Hernan Bazan, talks more about this exciting opportunity and what’s next in getting his drug to market.
